Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.20.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2020
Jun. 30, 2020
Accounts payable, related parties $ 124 $ 6
Accrued expenses, related parties $ 847 $ 705
Preferred Stock, No Par Value $ 0 $ 0
Preferred Stock, Shares Authorized 1,000,000 1,000,000
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 275,000,000 275,000,000
Common Stock, Shares, Issued 180,317,751 140,071,110
Common Stock, Shares, Outstanding 180,317,751 140,071,110
iBio CMO    
Preferred Stock, Shares Authorized 1 1
Preferred Stock, Shares Issued 1 1
Preferred Stock, Shares Outstanding 1 1
Series B Preferred Stock [Member]    
Preferred Stock, No Par Value $ 1,000 $ 1,000
Preferred Stock, Shares Authorized 5,785 5,785
Preferred Stock, Shares Issued 0 5,785
Preferred Stock, Shares Outstanding 0 5,785